Omnicin Therapeutics
PrivateLast Round
Grant
Feb 1, 2020
Company Overview
Omnicin Therapeutics is a pharmaceutical company that develops inhaled therapeutic platforms designed to restore antibiotic sensitivity in multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Omnicin Therapeutics Comparables
Compare Omnicin Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Helperby Therapeutics | 79% | |
| Revagenix, Inc. | 77% | |
| Spexis AG | 77% |
Omnicin Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2020 |
Omnicin Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Accelerator |
| Netherlands Organization for Scientific Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2020
Received grant from Netherlands Organization for Scientific Research.
Omnicin Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Omnicin Therapeutics's valuation, stock price, and market status.
Is Omnicin Therapeutics a public or private company?
Omnicin Therapeutics is a private company.
What is the current stock price of Omnicin Therapeutics?
Omnicin Therapeutics is a private company with no public stock price. Caplight tracks Omnicin Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Omnicin Therapeutics worth (valuation)?
Valuation information for Omnicin Therapeutics is not publicly available.
Can I buy Omnicin Therapeutics stock?
Omnicin Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Omnicin Therapeutics's last funding round?
Omnicin Therapeutics's most recent funding round was Grant on February 1, 2020.
Who are the main investors in Omnicin Therapeutics?
Key investors in Omnicin Therapeutics include INCATE, Netherlands Organization for Scientific Research.
Will Omnicin Therapeutics IPO soon?
No public IPO plans have been announced for Omnicin Therapeutics.
How can I track Omnicin Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Omnicin Therapeutics's secondary market activity and sign up for updates.